Loading insider details...
Latest Form 4 (Nov 3, 2026): Purchase of 66,666 ASPE shares, $1000.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Aspen Neuroscience, Inc. (ASPE) | Purchase | 66,666 | $1000.0K |
| Oct 29, 2025 | Neumora Therapeutics, Inc. (NMRA) | Purchase | 1,915,700 | $5.00M |
| Aug 1, 2025 | Prime Medicine, Inc. (PRME) | Purchase | 3,030,300 | $10.00M |
| Feb 20, 2024 | Prime Medicine, Inc. (PRME) | Purchase | 3,200,000 | $20.00M |
| Feb 12, 2024 | Sana Biotechnology, Inc. (SANA) | Purchase | 363,637 | $2.00M |
| Dec 13, 2023 | Neumora Therapeutics, Inc. (NMRA) | Other (see footnotes) | 703,061 | n/a |
| Sep 20, 2023 | Neumora Therapeutics, Inc. (NMRA) | Conversion | 684,167 | n/a |
| Oct 27, 2022 | Prime Medicine, Inc. (PRME) | Conversion | 5,728,297 | n/a |
| Jul 21, 2021 | Erasca, Inc. (ERAS) | Conversion | 5,527,777 | n/a |
| Feb 11, 2021 | Sana Biotechnology, Inc. (SANA) | Conversion | 10,156,250 | n/a |